
Nancy Pham
Articles
-
2 days ago |
insights.citeline.com | Marion Webb |Shubham Singh |Nancy Pham
Medtech Giants Brace for Tariffs Impact: Responses Range From Financial To Philosophical Manufacturing shifts, financial planning, and supply chain changes are among the adjustments that medtech leaders are making to Trump-era tariffs. Medtech Insight’s review of first-quarter earnings calls reveals how firms are navigating the impact and uncertainty of evolving trade policies.
-
Mar 7, 2025 |
insights.citeline.com | Sue Sutter |Derrick Gingery |Nancy Pham
Could Makary Face Facility Issues As US FDA Commissioner? The Department of Government Efficiency cancelled leases for FDA office and lab space at numerous sites outside the Washington, DC, area, while many buildings on the agency’s White Oak, MD, campus were included on the General Services Administration’s initial list of “non-core” government properties for disposal. The FDA's real property footprint could shrink under the second Trump Administration. (Shutterstock)
-
Feb 19, 2025 |
insights.citeline.com | Joseph Haas |Nancy Pham
Biopharma Deal Metrics Declined Across The Board In 2024INFOGRAPHIC: 2024 was a particularly quiet year for biopharma M&A, with no buyouts reaching the $5bn threshold, while alliance volume and valuations declined compared to 2023, as well. Dealmaking metrics declined sharply in 2024 (Shutterstock)
-
Feb 10, 2025 |
insights.citeline.com | Bridget Silverman |Nancy Pham |Kosh Naran
Novel Agents Up For US FDA Approval In 2025CBER has at least 14 and CDER another 10 novel biologics among the more than 60 candidates with a user fee goal in 2025. The FDA's 2025 user fee calendar includes a wide range of product types. (Shutterstock)
-
Jan 16, 2025 |
insights.citeline.com | Bridget Silverman |Nancy Pham
Clocking The Speed Of US FDA 2024 Novel ApprovalsReview times for all 61 novel agents the US FDA approved in 2024. The Pink Sheet calculated the review times for all the novel agents approved in 2024. (Shutterstock)
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →